EQUIVITAL INC

Equivital Inc. specializes in the design, development, and deployment of advanced physiological monitoring systems and wearable biosensor technologies for mission-critical applications. Leveraging expertise in biomedical signal processing, embedded systems, and real-time data acquisition, the company delivers ruggedized, FDA-regulated medical devices that capture continuous biometric data including ECG, respiration, activity, and temperature. Their technical focus includes low-power wireless communication protocols, edge computing for on-device analytics, and secure data transmission compliant with HIPAA and IEC 60601 standards. Differentiators include proprietary algorithms for motion artifact suppression and automated clinical alerting, enabling deployment in austere or mobile environments where continuous health surveillance is essential. Award history is not available to confirm specific agency engagements, but based on technical scope, their solutions are typically aligned with defense, public health, and emergency response missions requiring remote patient monitoring and field-deployable diagnostics. The company’s primary NAICS code, 334510, reflects its role as a manufacturer of electronic instrumentation for medical and physiological monitoring, positioning it within the medical device and health tech sector rather than general IT services. Equivital Inc. is structured as a small business under the 2L entity classification and operates from its headquarters in Great Neck, New York. While no government certifications are listed, its product development lifecycle adheres to regulatory frameworks governing Class II medical devices. The company maintains a focused market presence centered on hardware-software integrated systems for clinical and operational use cases, with no indication of broader geographic or multi-agency footprint beyond its New York base.